Edanz can support your needs for strategic planning and scientific messaging through:
Executing on a publication plan, or an individual project, we develop high-quality manuscripts and congress materials:
Edanz Pharma provides high-quality strategic planning and evidence generation services. Edanz was founded in Japan in 1995, and joined M3 Group (Tokyo Stock Exchange First Section -securities code 2413) in 2019.
We have a team of international experts with deep academic and industry experience.
*Since April 2021, the Edanz’s medical communications business is known as “Edanz Pharma”.
Edanz strictly adheres to international guidelines regarding medical writing best practice, including GPP3, ISMPP, EMWA, ICMJE guidelines.